Abbott Laboratories
ABL.XETRA
| Exchange: | XETRA |
| Currency | Euro |
| ISIN: | US0028241000 |
| LEI: | HQD377W2YR662HK5JX27 |
| Primary Ticker: | ABT.US |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Medical Devices |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Equipment & Supplies |
| Gic Sub Industry: | Health Care Equipment |
| Description: | Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-Co V-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. |
| Address: | 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 |
| Website: | https://www.abbott.com |
| Full Time Employees: | 114000 |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 189541793792 |
| Market Capitalization Mln: | 189541.79 |
| EBITDA: | 10824999936 |
| PE Ratio: | 36.18 |
| PEG Ratio: | 2.32 |
| Book Value: | 22.94 |
| Dividend Share: | 2.2 |
| Dividend Yield: | 0.01 |
| Earnings Share: | 3.02 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.13 |
| Operating Margin TTM: | 0.18 |
| Return On Assets TTM: | 0.06 |
| Return On Equity TTM: | 0.14 |
| Revenue TTM: | 41216999424 |
| Revenue Per Share TTM: | 23.68 |
| Quarterly Revenue Growth YOY: | 0.04 |
| Gross Profit TTM: | 24579000000 |
| Diluted Eps TTM: | 3.02 |
| Quarterly Earnings Growth YOY: | 0.14 |
Valuation
| Trailing PE: | 36.18 |
| Forward PE: | 23.25 |
| Price Sales TTM: | 4.59 |
| Price Book MRQ: | 5.21 |
| Enterprise Value: | 195605941387 |
| Enterprise Value Revenue: | 5.16 |
| Enterprise Value Ebitda: | 20.11 |
Shares
| Shares Outstanding: | 1734460032 |
| Shares Float: | 1723563555 |
| Percent Insiders: | 0.52 |
| Percent Institutions: | 79.77 |
Technicals
| Beta: | 0.72 |
| 52 Week High: | 110.6 |
| 52 Week Low: | 84.96 |
| 50 Day MA: | 104.33 |
| 200 Day MA: | 101.51 |
Splits & Dividends
| Forward Annual Dividend Rate: | 2.02 |
| Forward Annual Dividend Yield: | 0.01 |
| Payout Ratio: | 0.72 |
| Ex Dividend Date: | 2024-10-15 |
Earnings
| Report Date: | 2025-07-16 |
| Date: | 2025-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2025-04-15 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2025-01-22 |
| Date: | 2024-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2024-10-16 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.85 |
| Report Date: | 2024-07-18 |
| Date: | 2024-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.69 |
| Report Date: | 2024-04-17 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.64 |
| Report Date: | 2024-01-24 |
| Date: | 2023-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.84 |
| Report Date: | 2023-10-18 |
| Date: | 2023-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.75 |
| Report Date: | 2023-07-20 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.72 |
| Report Date: | 2023-04-19 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.70 |
| Report Date: | 2023-01-25 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.57 |
| Report Date: | 2022-10-19 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.80 |
| Report Date: | 2022-07-20 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 1.07 |
| Report Date: | 2022-04-20 |
| Date: | 2022-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | 1.22 |
| Report Date: | 2022-01-26 |
| Date: | 2021-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | 0.97 |
| Report Date: | 2021-10-20 |
| Date: | 2021-09-30 |
| Currency: | EUR |
| Eps Actual: | 0.99 |
| Report Date: | 2021-07-22 |
| Date: | 2021-06-30 |
| Currency: | EUR |
| Eps Actual: | 0.55 |
| Report Date: | 2021-04-20 |
| Date: | 2021-03-31 |
| Currency: | EUR |
| Eps Actual: | 0.83 |
| Report Date: | 2021-01-27 |
| Date: | 2020-12-31 |
| Currency: | EUR |
| Eps Actual: | 1.00 |
| Report Date: | 2020-10-21 |
| Date: | 2020-09-30 |
| Currency: | EUR |
| Eps Actual: | 0.58 |
| Report Date: | 2020-07-16 |
| Date: | 2020-06-30 |
| Currency: | EUR |
| Eps Actual: | 0.27 |
| Report Date: | 2020-04-16 |
| Date: | 2020-03-31 |
| Currency: | EUR |
| Eps Actual: | 0.28 |
| Report Date: | 2020-01-22 |
| Date: | 2019-12-31 |
| Currency: | EUR |
| Eps Actual: | 0.52 |
| Date: | 2024-09-30 |
| Eps Actual: | 2.19 |
| Date: | 2023-12-31 |
| Eps Actual: | 3.02 |
| Date: | 2022-12-31 |
| Eps Actual: | 3.68 |
| Date: | 2021-12-31 |
| Eps Actual: | 3.35 |
| Date: | 2020-12-31 |
| Eps Actual: | 2.15 |
| Date: | 2019-12-31 |
| Eps Actual: | 0.52 |